HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings in the community

The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD‐supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD‐supported patients. The expected and non‐expected device‐related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD‐supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD‐supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non‐LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non‐LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast‐growing population of LVAD‐supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD‐supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD‐supported patients.

[1]  O. Wever-Pinzon,et al.  Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. , 2020, JACC. Heart failure.

[2]  Low Cardiac Output , 2020, Definitions.

[3]  E. Girard,et al.  Feasibility and safety of laparoscopic colorectal surgeries for patients with left ventricular assist device , 2019, International Journal of Colorectal Disease.

[4]  M. Chung,et al.  Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control Strategies. , 2019, JACC. Clinical electrophysiology.

[5]  M. Walsh,et al.  A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.

[6]  M. Hannan,et al.  Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  G. Sayer,et al.  Unclear Benefit of Cardiac Resynchronization Therapy in Patients with Implanted Left Ventricular Assist Devices. , 2018, ASAIO journal (1992).

[8]  M. Morshuis,et al.  Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry , 2018, European heart journal.

[9]  Davor Milicic,et al.  Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[10]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[11]  Christopher R. Ellis,et al.  Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device , 2018, Journal of the American Heart Association.

[12]  S. Schueler,et al.  Algorithms to guide ambulance clinicians in the management of emergencies in patients with implanted rotary left ventricular assist devices , 2017, Emergency Medicine Journal.

[13]  M. Link,et al.  Cardiopulmonary Resuscitation in Adults and Children With Mechanical Circulatory Support: A Scientific Statement From the American Heart Association , 2017, Circulation.

[14]  A. Arıboğan,et al.  Resuscitation experience in a patient with left ventricular assist device. , 2016, Journal of clinical anesthesia.

[15]  I. Anand,et al.  Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. , 2016, JACC. Heart failure.

[16]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[17]  H. Mallidi,et al.  Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study. , 2015, Texas Heart Institute journal.

[18]  J. Herrin,et al.  Use of Post-acute Care Services and Readmissions After Left Ventricular Assist Device Implantation in Privately Insured Patients. , 2015, Journal of cardiac failure.

[19]  M. Walsh,et al.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. , 2015, Journal of cardiac failure.

[20]  C. Ayers,et al.  In-hospital cardiopulmonary arrests in patients with left ventricular assist devices. , 2014, Journal of cardiac failure.

[21]  N. Mabvuure,et al.  External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices. , 2014, Interactive cardiovascular and thoracic surgery.

[22]  Robert L Kormos,et al.  Sixth INTERMACS annual report: a 10,000-patient database. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  S. Chillcott,et al.  Chest compressions may be safe in arresting patients with left ventricular assist devices (LVADs). , 2014, Resuscitation.

[24]  W. Saliba,et al.  Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study). , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  Timothy J Nelson,et al.  Patients with heart failure have an increased risk of incident cancer. , 2013, Journal of the American College of Cardiology.

[26]  N. Uriel,et al.  Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? , 2013, Journal of the American College of Cardiology.

[27]  Nader Moazami,et al.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  H. May,et al.  Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[29]  Soon J. Park,et al.  Ventricular Fibrillation in an Ambulatory Patient Supported by a Left Ventricular Assist Device: Highlighting the ICD Controversy , 2012, ASAIO journal.

[30]  M. Haap,et al.  Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. , 2011, Annals of emergency medicine.

[31]  Dong Chen,et al.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. , 2010, The Annals of thoracic surgery.

[32]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  S. Russell,et al.  Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Finn Gustafsson,et al.  Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  D. Zimpfer,et al.  Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[36]  J. Lassen,et al.  A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy , 2002, Journal of internal medicine.

[37]  R. Doughty,et al.  Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. , 2002, European heart journal.

[38]  D. O'Brien,et al.  End-tidal carbon dioxide during extremely low cardiac output. , 1994, Annals of emergency medicine.

[39]  J. Ornato,et al.  Relationship between cardiac output and the end-tidal carbon dioxide tension. , 1990, Annals of emergency medicine.